Filed 9mo ago· Aug 25, 2025
96 days to disclose · 51 past 45-day window
Jonathan L. Jackson
DHouseIllinois-01
↓sold
Eli Lilly
LLY
$1K-$15K
+12.9% vs S&P 500
Trade dateMay 21, 2025
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–9 of 9
Filed 9mo ago· Aug 25, 2025
124 days to disclose · 79 past 45-day windowJonathan L. Jackson
DHouseIllinois-01
↑bought
Eli Lilly
LLY
$1K-$15K
+17.8% vs S&P 500
Trade dateApr 23, 2025
Filed 10mo ago· Jul 14, 2025
41 days to discloseJonathan L. Jackson
DHouseIllinois-01
↓sold
Eli Lilly
LLY
$15K-$50K
+11.6% vs S&P 500
Trade dateJun 3, 2025
Filed 1.1y ago· May 13, 2025
22 days to discloseJonathan L. Jackson
DHouseIllinois-01
↑bought
Eli Lilly
LLY
$15K-$50K
+17.0% vs S&P 500
Trade dateApr 21, 2025
Filed 1.5y ago· Dec 12, 2024
29 days to discloseJonathan L. Jackson
DHouseIllinois-01
↓sold
Regeneron Pharmaceuticals
REGN
$15K-$50K
+1.1% vs S&P 500
Trade dateNov 13, 2024
Common Stock
Filed 1.5y ago· Dec 12, 2024
41 days to discloseJonathan L. Jackson
DHouseIllinois-01
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
+0.5% vs S&P 500
Trade dateNov 1, 2024
Common Stock
Filed 1.6y ago· Oct 11, 2024
17 days to discloseJonathan L. Jackson
DHouseIllinois-01
↓sold
Merck
MRK
$15K-$50K
+24.9% vs S&P 500
Trade dateSep 24, 2024
Stock
Filed 2.3y ago· Feb 15, 2024
29 days to discloseJonathan L. Jackson
DHouseIllinois-01
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−70.1% vs S&P 500
Trade dateJan 17, 2024
Common Stock
Filed 2.9y ago· Jul 7, 2023
14 days to discloseJonathan L. Jackson
DHouseIllinois-01
↑bought
Regeneron Pharmaceuticals
REGN
$15K-$50K
−20.0% vs S&P 500
Trade dateJun 23, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 25, 2025 9mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | May 21, 2025 96 days to disclose · 51 past 45-day window | Flat·+0.0% +12.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 25, 2025 9mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 23, 2025 124 days to disclose · 79 past 45-day window | Good buy·+$2.2K+27.3% +17.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Eli Lilly LLY | Jun 3, 2025 41 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 13, 2025 1.1y ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Eli Lilly LLY | Apr 21, 2025 22 days to disclose | Good buy·+$9.4K+29.0% +17.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 12, 2024 1.5y ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Nov 13, 2024 29 days to disclose | Flat·+0.0% +1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 12, 2024 1.5y ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock | Nov 1, 2024 41 days to disclose | Flat·+0.0% +0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2024 1.6y ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Merck MRK Stock | Sep 24, 2024 17 days to disclose | Flat·+0.0% +24.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 15, 2024 2.3y ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock | Jan 17, 2024 29 days to disclose | Bad buy·−$1.5K-18.9% −70.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 7, 2023 2.9y ago | Jonathan L. Jackson DHouseIllinois-01 | ↑bought | Regeneron Pharmaceuticals REGN | Jun 23, 2023 14 days to disclose | Bad buy·−$2.4K-7.5% −20.0% vs S&P 500 | $15K-$50K midpoint $32.5K |